A/Prof. Cameron Shaw

Changes in employment status over time in multiple sclerosis following a first episode of central nervous system demyelination, a Markov multistate model study

A Zarghami, V Fuh-Ngwa, S Claflin, I van der Mei, A Ponsonby, S Broadley, S Simpson-Yap, R Lucas, K Dear, A Ponsonby, I van der Mei, L Blizzard, S Simpson-Yap, B Taylor, S Broadley, T Kilpatrick, D Williams, J Lechner-Scott, C Shaw, C Chapman, A Coulthard, P Valery, B Taylor

(2024), Vol. 31, pp. 1-11, European Journal of Neurology, London, Eng., C1

Neurological Health: Not Merely the Absence of Disease: Current Wellbeing Instruments Across the Spectrum of Neurology

B Ziegeler, W D’ Souza, A Vinton, S Mulukutla, C Shaw, R Carne

(2023), Vol. 17, pp. 299-316, American Journal of Lifestyle Medicine, London, Eng., C1

Comparative effectiveness in multiple sclerosis: A methodological comparison

I Roos, I Diouf, S Sharmin, D Horakova, E Havrdova, F Patti, V Shaygannejad, S Ozakbas, G Izquierdo, S Eichau, M Onofrj, A Lugaresi, R Alroughani, A Prat, M Girard, P Duquette, M Terzi, C Boz, F Grand’Maison, P Sola, D Ferraro, P Grammond, R Turkoglu, K Buzzard, O Skibina, B Yamou, A Altintas, O Gerlach, V van Pesch, Y Blanco, D Maimone, J Lechner-Scott, R Bergamaschi, R Karabudak, C McGuigan, E Cartechini, M Barnett, S Hughes, M Sa, C Solaro, C Ramo-Tello, S Hodgkinson, D Spitaleri, A Soysal, T Petersen, F Granella, K de Gans, P McCombe, R Ampapa, B Van Wijmeersch, A van der Walt, H Butzkueven, J Prevost, J Sanchez-Menoyo, G Laureys, R Gouider, T Castillo-Triviño, O Gray, E Aguera-Morales, A Al-Asmi, C Shaw, N Deri, T Al-Harbi, Y Fragoso, T Csepany, A Sempere, I Trevino-Frenk, J Schepel, F Moore, C Malpas, T Kalincik

(2023), Vol. 29, pp. 326-332, Multiple Sclerosis Journal, London, Eng., C1-1

Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

I Diouf, C Malpas, S Sharmin, I Roos, D Horakova, E Havrdova, F Patti, V Shaygannejad, S Ozakbas, G Izquierdo, S Eichau, M Onofrj, A Lugaresi, R Alroughani, A Prat, M Girard, P Duquette, M Terzi, C Boz, F Grand'Maison, S Hamdy, P Sola, D Ferraro, P Grammond, R Turkoglu, K Buzzard, O Skibina, B Yamout, A Altintas, O Gerlach, V van Pesch, Y Blanco, D Maimone, J Lechner-Scott, R Bergamaschi, R Karabudak, G Iuliano, C McGuigan, E Cartechini, M Barnett, S Hughes, M Sa, C Solaro, L Kappos, C Ramo-Tello, E Cristiano, S Hodgkinson, D Spitaleri, A Soysal, T Petersen, M Slee, E Butler, F Granella, K de Gans, P McCombe, R Ampapa, B Van Wijmeersch, A van der Walt, H Butzkueven, J Prevost, L Sinnige, J Sanchez-Menoyo, S Vucic, G Laureys, L Van Hijfte, D Khurana, R Macdonell, R Gouider, T Castillo-Triviño, O Gray, E Aguera-Morales, A Al-Asmi, C Shaw, N Deri, T Al-Harbi, Y Fragoso, T Csepany, A Perez Sempere, I Trevino-Frenk, J Schepel, F Moore, T Kalincik

(2023), Vol. 30, pp. 1014-1024, European Journal of Neurology, London, Eng., C1-1

A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study

A Saul, B Taylor, L Blizzard, S Simpson-Yap, W Oddy, N Shivappa, J Hébert, L Black, A Ponsonby, S Broadley, J Lechner-Scott, I van der Mei, R Lucas, K Dear, T Dwyer, S Broadley, T Kilpatrick, D Williams, C Shaw, C Chapman, A Coulthard, M Pender, P Valery

(2023), Vol. 29, pp. 1012-1023, Multiple Sclerosis Journal, C1

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

C Daruwalla, V Shaygannejad, S Ozakbas, E Havrdova, D Horakova, R Alroughani, C Boz, F Patti, M Onofrj, A Lugaresi, S Eichau, M Girard, A Prat, P Duquette, B Yamout, S Khoury, S Sajedi, R Turkoglu, A Altintas, O Skibina, K Buzzard, P Grammond, R Karabudak, A van der Walt, H Butzkueven, D Maimone, J Lechner-Scott, A Soysal, N John, J Prevost, D Spitaleri, C Ramo-Tello, O Gerlach, G Iuliano, M Foschi, R Ampapa, V van Pesch, M Barnett, N Shalaby, M D'hooghe, J Kuhle, M Sa, M Fabis-Pedrini, A Kermode, S Mrabet, R Gouider, S Hodgkinson, G Laureys, L Van Hijfte, R Macdonell, C Oreja-Guevara, E Cristiano, P McCombe, J Sanchez-Menoyo, B Singhal, Y Blanco, S Hughes, J Garber, C Solaro, C McGuigan, B Taylor, K de Gans, M Habek, A Al-Asmi, S Mihaela, T Castillo Triviño, T Al-Harbi, J Rojas, O Gray, D Khurana, B Van Wijmeersch, N Grigoriadis, J Inshasi, J Oh, E Aguera-Morales, Y Fragoso, F Moore, C Shaw, S Baghbanian, N Shuey, B Willekens, T Hardy, D Decoo, A Sempere, D Field, R Wynford-Thomas, N Cunniffe, I Roos, C Malpas, A Coles, T Kalincik, J Brown

(2023), Vol. 29, pp. 875-883, Multiple Sclerosis Journal, London, Eng., C1-1

Longitudinal epidemiology of multiple sclerosis in Townsville, Queensland, Australia, 2012-2022

S Simpson-Yap, D Maddox, J Reece, J Lechner-Scott, C Shaw, B Taylor, T Kalincik, A van der Walt, M Boggild

(2023), Vol. 77, pp. 1-10, Multiple Sclerosis and Related Disorders, Amsterdam, The Netherlands, C1

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

S Sharmin, I Roos, S Simpson-Yap, C Malpas, M Sánchez, S Ozakbas, D Horakova, E Havrdova, F Patti, R Alroughani, G Izquierdo, S Eichau, C Boz, M Zakaria, M Onofrj, A Lugaresi, B Weinstock-Guttman, A Prat, M Girard, P Duquette, M Terzi, M Amato, R Karabudak, F Grand'Maison, S Khoury, P Grammond, J Lechner-Scott, K Buzzard, O Skibina, A van der Walt, H Butzkueven, R Turkoglu, A Altintas, D Maimone, A Kermode, N Shalaby, V Pesch, E Butler, Y Sidhom, R Gouider, S Mrabet, O Gerlach, A Soysal, M Barnett, J Kuhle, S Hughes, M Sa, S Hodgkinson, C Oreja-Guevara, R Ampapa, T Petersen, C Ramo-Tello, D Spitaleri, P McCombe, B Taylor, J Prevost, M Foschi, M Slee, C McGuigan, G Laureys, L Hijfte, K de Gans, C Solaro, J Oh, R Macdonell, E Aguera-Morales, B Singhal, O Gray, J Garber, B Wijmeersch, M Simu, T Castillo-Triviño, J Sanchez-Menoyo, D Khurana, A Al-Asmi, T Al-Harbi, N Deri, Y Fragoso, P Lalive, L Sinnige, C Shaw, N Shuey, T Csepany, A Sempere, F Moore, D Decoo, B Willekens, C Gobbi, J Massey, T Hardy, J Parratt, T Kalincik

(2023), Vol. 146, pp. 4633-4644, Brain, Oxford, Eng., C1-1

Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial

I Diouf, C Malpas, S Sharmin, I Roos, D Horakova, E Kubala Havrdova, F Patti, V Shaygannejad, S Ozakbas, S Eichau, M Onofrj, A Lugaresi, R Alroughani, A Prat, P Duquette, M Terzi, C Boz, F Grand'maison, P Sola, D Ferraro, P Grammond, B Yamout, A Altintas, O Gerlach, J Lechner-Scott, R Bergamaschi, R Karabudak, G Iuliano, C McGuigan, E Cartechini, S Hughes, M Sa, C Solaro, L Kappos, S Hodgkinson, M Slee, F Granella, K De Gans, P McCombe, R Ampapa, A Van Der Walt, H Butzkueven, J Sánchez-Menoyo, S Vucic, G Laureys, Y Sidhom, R Gouider, T Castillo-Trivino, O Gray, E Aguera-Morales, A Al-Asmi, C Shaw, T Al-Harbi, T Csepany, A Sempere, I Treviño Frenk, E Stuart, T Kalincik

(2023), Vol. 94, pp. 1004-1011, Journal of Neurology, Neurosurgery and Psychiatry, London, Eng., C1-1

NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand

W Bukhari, E Khalilidehkordi, D Mason, M Barnett, B Taylor, M Fabis-Pedrini, A Kermode, S Subramanian, P Waters, S Broadley, S Broadley, D Abernethy, S Bhuta, S Blum, M Boggild, K Boundy, B Brew, F Brilot, W Brownlee, C Bundell, H Butzkueven, W Carroll, C Chen, L Clarke, A Coulthard, R Dale, C Das, K Dear, D Fulcher, D Gillis, S Hawke, R Heard, A Henderson, S Heshmat, S Hodgkinson, S Jimenez Sanchez, T Kilpatrick, J King, C Kneebone, A Kornberg, J Lechner-Scott, M Lin, C Lynch, R Macdonell, M Marriott, P McCombe, C O’Gorman, J Parratt, M Pender, J Pereira, J Pollard, K Prain, S Ramanathan, S Reddell, C Shaw, R Silvestrini, M Slee, J Spies, J Stankovich, I Sutton, A Vincent, S Vucic, M Walsh, E Willoughby, R Wong, M Woodhall, E Yiu

(2022), Vol. 269, pp. 836-845, Journal of Neurology, Germany, C1

Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study

M Vitkova, I Diouf, C Malpas, D Horakova, E Kubala Havrdova, F Patti, S Ozakbas, G Izquierdo, S Eichau, V Shaygannejad, M Onofrj, A Lugaresi, R Alroughani, A Prat, C Larochelle, M Girard, P Duquette, M Terzi, C Boz, F Grand'maison, P Sola, D Ferraro, P Grammond, H Butzkueven, K Buzzard, O Skibina, B Yamout, R Karabudak, O Gerlach, J Lechner-Scott, D Maimone, R Bergamaschi, V Van Pesch, G Iuliano, E Cartechini, M José Sà, R Ampapa, M Barnett, S Hughes, C Ramo-Tello, S Hodgkinson, D Spitaleri, T Petersen, E Butler, M Slee, C McGuigan, P McCombe, F Granella, E Cristiano, J Prevost, B Taylor, J Sãnchez-Menoyo, G Laureys, L Van Hijfte, S Vucic, R MacDonell, O Gray, J Olascoaga, N Deri, Y Fragoso, C Shaw, T Kalincik

(2022), Vol. 98, pp. E2401-E2412, Neurology, United States, C1

Confirmed disability progression as a marker of permanent disability in multiple sclerosis

S Sharmin, F Bovis, C Malpas, D Horakova, E Havrdova, G Izquierdo, S Eichau, M Trojano, A Prat, M Girard, P Duquette, M Onofrj, A Lugaresi, F Grand'Maison, P Grammond, P Sola, D Ferraro, M Terzi, O Gerlach, R Alroughani, C Boz, V Shaygannejad, V van Pesch, E Cartechini, L Kappos, J Lechner-Scott, R Bergamaschi, R Turkoglu, C Solaro, G Iuliano, F Granella, B Van Wijmeersch, D Spitaleri, M Slee, P McCombe, J Prevost, R Ampapa, S Ozakbas, J Sanchez-Menoyo, A Soysal, S Vucic, T Petersen, K de Gans, E Butler, S Hodgkinson, Y Sidhom, R Gouider, E Cristiano, T Castillo-Triviño, M Saladino, M Barnett, F Moore, C Rozsa, B Yamout, O Skibina, A van der Walt, K Buzzard, O Gray, S Hughes, A Sempere, B Singhal, Y Fragoso, C Shaw, A Kermode, B Taylor, M Simo, N Shuey, T Al-Harbi, R Macdonell, J Dominguez, T Csepany, C Sirbu, M Sormani, H Butzkueven, T Kalincik

(2022), Vol. 29, pp. 2321-2334, European Journal of Neurology, England, C1-1

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

M Lefort, S Sharmin, J Andersen, S Vukusic, R Casey, M Debouverie, G Edan, J Ciron, A Ruet, J De Sèze, E Maillart, H Zephir, P Labauge, G Defer, C Lebrun-Frenay, T Moreau, E Berger, P Clavelou, J Pelletier, B Stankoff, O Gout, E Thouvenot, O Heinzlef, A Al-Khedr, B Bourre, O Casez, P Cabre, A Montcuquet, A Wahab, J Camdessanché, A Maurousset, H Ben Nasr, K Hankiewicz, C Pottier, N Maubeuge, D Dimitri-Boulos, C Nifle, D Laplaud, D Horakova, E Havrdova, R Alroughani, G Izquierdo, S Eichau, S Ozakbas, F Patti, M Onofrj, A Lugaresi, M Terzi, P Grammond, F Grand’Maison, B Yamout, A Prat, M Girard, P Duquette, C Boz, M Trojano, P McCombe, M Slee, J Lechner-Scott, R Turkoglu, P Sola, D Ferraro, F Granella, V Shaygannejad, J Prevost, D Maimone, O Skibina, K Buzzard, A Van der Walt, R Karabudak, B Van Wijmeersch, T Csepany, D Spitaleri, S Vucic, N Koch-Henriksen, F Sellebjerg, P Soerensen, C Hilt Christensen, P Rasmussen, M Jensen, J Frederiksen, S Bramow, H Mathiesen, K Schreiber, H Butzkueven, M Magyari, T Kalincik, E Leray

(2022), Vol. 22, pp. 155-, BMC Medical Research Methodology, England, C1

Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data

T Hardy, J Parratt, H Beadnall, S Blum, R Macdonell, R Beran, N Shuey, A Lee, W Carroll, C Shaw, R Worrell, J Moody, M Sedhom, M Barnett, S Vucic

(2022), Vol. 4, BMJ Neurology Open, England, C1

Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination

A Zarghami, I van der Mei, M Hussain, S Claflin, B Bessing, S Simpson-Yap, A Ponsonby, J Lechner-Scott, S Broadley, L Blizzard, K Dear, T Dwyer, B Taylor, T Kilpatrick, D Williams, C Shaw, C Chapman, A Coulthard, M Pender, P Valery

(2022), Vol. 28, pp. 1793-1807, Multiple Sclerosis Journal, England, C1-1

Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy

N Lizak, S Hodgkinson, E Butler, J Lechner-Scott, M Slee, P McCombe, C Shaw, O Skibina, S Vucic, N Shuey, M Barnett, J Parratt, H Butzkueven, D Jack, J Fabris, T Kalincik

(2021), Vol. 27, pp. 465-474, Multiple Sclerosis Journal, England, C1

High Prudent diet factor score predicts lower relapse hazard in early multiple sclerosis

S Simpson-Yap, W Oddy, B Taylor, R Lucas, L Black, A Ponsonby, L Blizzard, I van der Mei, K Dear, T Dwyer, B Taylor, S Broadley, T Kilpatrick, D Williams, J Lechner-Scott, C Shaw, C Chapman, A Coulthard, M Pender, P Valery

(2021), Vol. 27, pp. 1112-1124, Multiple Sclerosis Journal, England, C1

Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

T Kalincik, I Diouf, S Sharmin, C Malpas, T Spelman, D Horakova, E Havrdova, M Trojano, G Izquierdo, A Lugaresi, A Prat, M Girard, P Duquette, P Grammond, V Jokubaitis, A van der Walt, F Grand'Maison, P Sola, D Ferraro, V Shaygannejad, R Alroughani, R Hupperts, M Terzi, C Boz, J Lechner-Scott, E Pucci, V Van Pesch, F Granella, R Bergamaschi, D Spitaleri, M Slee, S Vucic, R Ampapa, P McCombe, C Ramo-Tello, J Prevost, J Olascoaga, E Cristiano, M Barnett, M Saladino, J Sanchez-Menoyo, S Hodgkinson, C Rozsa, S Hughes, F Moore, C Shaw, E Butler, O Skibina, O Gray, A Kermode, T Csepany, B Singhal, N Shuey, I Piroska, B Taylor, M Simo, C Sirbu, A Sas, H Butzkueven

(2021), Vol. 96, pp. e783-e797, Neurology, Hagerstown, Md., C1

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis

L Clarke, S Arnett, W Bukhari, E Khalilidehkordi, S Jimenez Sanchez, C O'Gorman, J Sun, K Prain, M Woodhall, R Silvestrini, C Bundell, D Abernethy, S Bhuta, S Blum, M Boggild, K Boundy, B Brew, W Brownlee, H Butzkueven, W Carroll, C Chen, A Coulthard, R Dale, C Das, M Fabis-Pedrini, D Gillis, S Hawke, R Heard, A Henderson, S Heshmat, S Hodgkinson, T Kilpatrick, J King, C Kneebone, A Kornberg, J Lechner-Scott, M Lin, C Lynch, R Macdonell, D Mason, P McCombe, J Pereira, J Pollard, S Ramanathan, S Reddel, C Shaw, J Spies, J Stankovich, I Sutton, S Vucic, M Walsh, R Wong, E Yiu, M Barnett, A Kermode, M Marriott, J Parratt, M Slee, B Taylor, E Willoughby, F Brilot, A Vincent, P Waters, S Broadley

(2021), Vol. 12, Frontiers in Neurology, Switzerland, C1

Risk of secondary progressive multiple sclerosis: a longitudinal study

A Fambiatos, V Jokubaitis, D Horakova, E Kubala Havrdova, M Trojano, A Prat, M Girard, P Duquette, A Lugaresi, G Izquierdo, F Grand’Maison, P Grammond, P Sola, D Ferraro, R Alroughani, M Terzi, R Hupperts, C Boz, J Lechner-Scott, E Pucci, R Bergamaschi, V Van Pesch, S Ozakbas, F Granella, R Turkoglu, G Iuliano, D Spitaleri, P McCombe, C Solaro, M Slee, R Ampapa, A Soysal, T Petersen, J Sanchez-Menoyo, F Verheul, J Prevost, Y Sidhom, B Van Wijmeersch, S Vucic, E Cristiano, M Saladino, N Deri, M Barnett, J Olascoaga, F Moore, O Skibina, O Gray, Y Fragoso, B Yamout, C Shaw, B Singhal, N Shuey, S Hodgkinson, A Altintas, T Al-Harbi, T Csepany, B Taylor, J Hughes, J Jun, A van der Walt, T Spelman, H Butzkueven, T Kalincik

(2020), Vol. 26, pp. 79-90, Multiple sclerosis journal, London, Eng., C1

Redefining the Multiple Sclerosis Severity Score (MSSS): the effect of sex and onset phenotype

Y Zhou, S Claflin, J Stankovich, I van der Mei, S Simpson, R Roxburgh, T Kalincik, L Blizzard, A Lugaresi, R Alroughani, S Sajedi, H Butzkueven, E Pucci, D Spitaleri, F Granella, E Cristiano, B Yamout, S Hughes, R Gouider, J Sánchez Menoyo, J Olascoaga, C McGuigan, C Shaw, A Kermode, K Kasa, T Al-Harbi, A Altintas, G Laureys, Y Fragoso, T Hardy, T Csepany, C Sirbu, D Decoo, A Sas, J Alvarez-Cermeño, K Kotkata, J Millán-Pascual, B Taylor

(2020), Vol. 26, pp. 1765-1774, Multiple sclerosis journal, London, Eng., C1

The clinical profile of NMOSD in Australia and New Zealand

W Bukhari, L Clarke, C O’Gorman, E Khalilidehkordi, S Arnett, K Prain, M Woodhall, R Silvestrini, C Bundell, S Ramanathan, D Abernethy, S Bhuta, S Blum, M Boggild, K Boundy, B Brew, W Brownlee, H Butzkueven, W Carroll, C Chen, A Coulthard, R Dale, C Das, K Dear, M Fabis-Pedrini, D Fulcher, D Gillis, S Hawke, R Heard, A Henderson, S Heshmat, S Hodgkinson, S Jimenez-Sanchez, T Kilpatrick, J King, C Kneebone, A Kornberg, J Lechner-Scott, M Lin, C Lynch, R Macdonnell, D Mason, P McCombe, J Pereira, J Pollard, S Reddel, C Shaw, J Spies, J Stankovich, I Sutton, S Vucic, M Walsh, R Wong, E Yiu, M Barnett, A Kermode, M Marriott, J Parratt, M Slee, B Taylor, E Willoughby, R Wilson, F Brilot, A Vincent, P Waters, S Broadley

(2020), Vol. 267, pp. 1431-1443, Journal of neurology, Berlin, Germany, C1

Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder

A Kunchok, C Malpas, P Nytrova, E Havrdova, R Alroughani, M Terzi, B Yamout, J Hor, R Karabudak, C Boz, S Ozakbas, J Olascoaga, M Simo, F Granella, F Patti, P McCombe, T Csepany, B Singhal, R Bergamaschi, Y Fragoso, T Al-Harbi, R Turkoglu, J Lechner-Scott, G Laureys, C Oreja-Guevara, E Pucci, P Sola, D Ferraro, A Altintas, A Soysal, S Vucic, F Grand'Maison, G Izquierdo, S Eichau, A Lugaresi, M Onofrj, M Trojano, M Marriott, H Butzkueven, I Kister, T Kalincik

(2020), Vol. 38, pp. 1-8, Multiple sclerosis and related disorders, Amsterdam, The Netherlands, C1

Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation

E Khalilidehkordi, L Clarke, S Arnett, W Bukhari, S Jimenez Sanchez, C O'Gorman, J Sun, K Prain, M Woodhall, R Silvestrini, C Bundell, D Abernethy, S Bhuta, S Blum, M Boggild, K Boundy, B Brew, M Brown, W Brownlee, H Butzkueven, W Carroll, C Chen, A Coulthard, R Dale, C Das, M Fabis-Pedrini, D Fulcher, D Gillis, S Hawke, R Heard, A Henderson, S Heshmat, S Hodgkinson, T Kilpatrick, J King, C Kneebone, A Kornberg, J Lechner-Scott, M Lin, C Lynch, R Macdonell, D Mason, P McCombe, J Pereira, J Pollard, S Ramanathan, S Reddel, C Shaw, J Spies, J Stankovich, I Sutton, S Vucic, M Walsh, R Wong, E Yiu, M Barnett, A Kermode, M Marriott, J Parratt, M Slee, B Taylor, E Willoughby, F Brilot, A Vincent, P Waters, S Broadley

(2020), Vol. 11, Frontiers in Neurology, Switzerland, C1

Delay from treatment start to full effect of immunotherapies for multiple sclerosis

I Roos, E Leray, F Frascoli, R Casey, W Brown, D Horakova, E Havrdova, M Trojano, F Patti, G Izquierdo, S Eichau, M Onofrj, A Lugaresi, A Prat, M Girard, P Grammond, P Sola, D Ferraro, S Ozakbas, R Bergamaschi, M Sá, E Cartechini, C Boz, F Granella, R Hupperts, M Terzi, J Lechner-Scott, D Spitaleri, V van Pesch, A Soysal, J Olascoaga, J Prevost, E Aguera-Morales, M Slee, T Csepany, R Turkoglu, Y Sidhom, R Gouider, B van Wijmeersch, P McCombe, R Macdonell, A Coles, C Malpas, H Butzkueven, S Vukusic, T Kalincik, P Duquette, F Grand'Maison, G Iuliano, C Ramo-Tello, C Solaro, J Cabrera-Gomez, M Rio, R Bolaños, V Shaygannejad, C Oreja-Guevara, J Sanchez-Menoyo, T Petersen, A Altintas, M Barnett, S Flechter, Y Fragoso, M Amato, F Moore, R Ampapa, F Verheul, S Hodgkinson, E Cristiano, B Yamout, G Laureys, J Dominguez, C Zwanikken, N Deri, E Dobos, C Vrech, E Butler, C Rozsa, T Petkovska-Boskova, R Karabudak, C Rajda, J Alkhaboori, M Saladino, C Shaw, N Shuey, S Vucic, A Sempere, J Campbell, I Piroska, B Taylor, A van der Walt, L Kappos, E Roullet, O Gray, M Simo, C Sirbu, B Brochet, F Cotton, J de Sèze, A Dion, P Douek

(2020), Vol. 143, pp. 2742-2756, Brain, Oxford, Eng., C1

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: a contemporary cohort study

Ai-Lan Nguyen, Eva Havrdova, Dana Horakova, Guillermo Izquierdo, Tomas Kalincik, Anneke van der Walt, Murat Terzi, Raed Alroughani, Pierre Duquette, Marc Girard, Alexandre Prat, Cavit Boz, Patrizia Sola, Diana Ferraro, Alessandra Lugaresi, Jeannette Lechner-Scott, Michael Barnett, Francois Grand'Maison, Pierre Grammond, Cristina Ramo-Tello, Recai Turkoglu, Pamela McCombe, Eugenio Pucci, Maria Trojano, Franco Granella, Daniele Spitaleri, Vincent Van Pesch, Aysun Soysal, Celia Oreja-Guevara, Freek Verheul, Steve Vucic, Suzanne Hodgkinson, Mark Slee, Radek Ampapa, Julie Prevost, Jose Menoyo, Olga Skibina, Claudio Solaro, Javier Olascoaga, Cameron Shaw, Klaus Madsen, Kerisha Naidoo, Robert Hyde, Helmut Butzkueven, Vilija Jokubaitis, MSBase Study Group

(2019), Vol. 28, pp. 235-243, Multiple sclerosis and related disorders, Amsterdam, The Netherlands, C1

Common genetic variation within miR-146a predicts disease onset and relapse in multiple sclerosis

Y Zhou, M Chen, S Simpson, R Lucas, J Charlesworth, N Blackburn, I van der Mei, A Ponsonby, B Taylor, R Lucas, K Dear, T Dwyer, L Blizzard, S Simpson, B Taylor, S Broadley, T Kilpatrick, D Williams, J Lechner-Scott, C Shaw, C Chapman, A Coulthard, P Valery

(2018), Vol. 39, pp. 297-304, Neurological Sciences, Berlin, Germany, C1-1

Sun exposure across the life course significantly modulates early multiple sclerosis clinical course

S Simpson, I Van Der Mei, R Lucas, A Ponsonby, S Broadley, L Blizzard, K Dear, T Dwyer, B Taylor, T Kilpatrick, D Williams, J Lechner-Scott, C Shaw, C Chapman, A Coulthard, M Pender, P Valery, B Taylor

(2018), Vol. 9, pp. 1-17, Frontiers in neurology, Lausanne, Switzerland, C1

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis

T Kalincik, V Jokubaitis, T Spelman, D Horakova, E Havrdova, M Trojano, J Lechner-Scott, A Lugaresi, A Prat, M Girard, P Duquette, P Grammond, C Solaro, F Grand Maison, R Hupperts, J Prevost, P Sola, D Ferraro, M Terzi, E Butler, M Slee, A Kermode, M Fabis-Pedrini, P McCombe, M Barnett, C Shaw, S Hodgkinson, H Butzkueven

(2018), Vol. 24, pp. 1617-1626, Multiple sclerosis journal, London, Eng., C1-1

Onset symptoms, tobacco smoking, and progressive-onset phenotype are associated with a delayed onset of multiple sclerosis, and marijuana use with an earlier onset

C Tao, S Simpson, B Taylor, L Blizzard, R Lucas, A Ponsonby, S Broadley, I van der Mei, C Shaw

(2018), Vol. 9, Frontiers in Neurology, Lausanne, Switzerland, C1

Association of inflammation and disability accrual in patients with progressive-onset multiple sclerosis

J Hughes, V Jokubaitis, A Lugaresi, R Hupperts, G Izquierdo, A Prat, M Girard, P Duquette, F Grand'maison, P Grammond, P Sola, D Ferraro, C Ramo-Tello, M Trojano, M Slee, V Shaygannejad, C Boz, J Lechner-Scott, V Van Pesch, E Pucci, C Solaro, F Verheul, M Terzi, F Granella, D Spitaleri, R Alroughani, J Jun, A Fambiatos, A Van Der Walt, H Butzkueven, T Kalincik, G De Luca, V Di Tommaso, D Travaglini, E Pietrolongo, M Di Ioia, D Farina, L Mancinelli, F Vitetta, A Simone, J Haartsen, T Spelman, M Marriott, T Kilpatrick, J King, K Buzzard, A Nguyen, C Dwyer, M Monif, J Brown, A Kunchok, M DIamanti, E Cartechini, E Curti, E Tsantes, C Zwanikken, M Rio, S Hughes, M Amato, B Van Wijmeersch, J Sanchez-Menoyo, R Bolaños, S Sajedi, G Iuliano, L Den Braber-Moerland, J Prevost, A Sempere, Y Sidhom, E Butler, S Vucic, B Taylor, J Cabrera-Gomez, C Oreja-Guevara, R Bergamaschi, R Turkoglu, J Olascoaga, E Cristiano, J Rojas, S Hodgkinson, O Skibina, T Al-Harbi, A Altintas, P McCombe, L Sinnige, S Ozakbas, M Saladino, E Bacile, C Vrech, C Shaw

(2018), Vol. 75, pp. 1407-1415, JAMA neurology, Chicago, Ill., C1

An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event

P Tettey, S Simpson, B Taylor, A-L Ponsonby, R Lucas, T Dwyer, K Kostner, AUSLONG investigators group, I van der Mei, C Shaw

(2017), Vol. 88, pp. 395-401, Journal of Neurology, Neurosusrgery & Psychiatry, London, Eng., C1-1

Variation within MBP gene predicts disease course in multiple sclerosis

Y Zhou, S Simpson, J Charlesworth, I van der Mei, R Lucas, A-L Ponsonby, AUSLONG Investigators Group, B Taylor, C Shaw

(2017), Vol. 7, pp. 1-6, Brain and behavior, Chichester, Eng., C1-1

Contribution of different relapse phenotypes to disability in multiple sclerosis

T Stewart, T Spelman, E Havrdova, D Horakova, M Trojano, G Izquierdo, P Duquette, M Girard, A Prat, A Lugaresi, F Grand'Maison, P Grammond, P Sola, V Shaygannejad, R Hupperts, R Alroughani, C Oreja-Guevara, E Pucci, C Boz, J Lechner-Scott, R Bergamaschi, V Van Pesch, G Iuliano, C Ramo, B Taylor, M Slee, D Spitaleri, F Granella, F Verheul, P McCombe, S Hodgkinson, M Amato, S Vucic, O Gray, E Cristiano, M Barnett, J Sanchez Menoyo, E Van Munster, M Saladino, J Olascoaga, J Prevost, N Deri, C Shaw, B Singhal, F Moore, C Rozsa, N Shuey, O Skibina, I Kister, T Petkovska-Boskova, R Ampapa, A Kermode, H Butzkueven, V Jokubaitis, T Kalincik

(2017), Vol. 23, pp. 266-276, Multiple Sclerosis Journal, London, Eng., C1-1

Incidence and prevalence of NMOSD in Australia and New Zealand

W Bukhari, K Prain, P Waters, M Woodhall, C O'Gorman, L Clarke, R Silvestrini, C Bundell, D Abernethy, S Bhuta, S Blum, M Boggild, K Boundy, B Brew, M Brown, W Brownlee, H Butzkueven, W Carroll, C Chen, A Coulthard, R Dale, C Das, K Dear, M Fabis-Pedrini, D Fulcher, D Gillis, S Hawke, R Heard, A Henderson, S Heshmat, S Hodgkinson, S Jimenez-Sanchez, T Killpatrick, J King, C Kneebone, A Kornberg, J Lechner-Scott, M-W Lin, C Lynch, R Macdonell, D Mason, P McCombe, M Pender, J Pereira, J Pollard, S Reddel, C Shaw, J Spies, J Stankovich, I Sutton, S Vucic, M Walsh, R Wong, E Yiu, M Barnett, A Kermode, M Marriott, J Parratt, M Slee, B Taylor, E Willoughby, R Wilson, A Vincent, S Broadley

(2017), Vol. 88, pp. 632-638, Journal of neurology, neurosurgery, and psychiatry, London, Eng., C1

Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: a multicentre Australian cohort study

C Odenthal, S Simpson, J Oughton, I van der Mei, S Rose, J Fripp, R Lucas, B Taylor, K Dear, A-L Ponsonby, A Coulthard, Ausimmune AusLong Investigator Groups, C Shaw

(2017), Vol. 61, pp. 453-460, Journal of medical imaging and radiation oncology, Chichester, Eng., C1

Anxiety, depression and fatigue at 5-year review following CNS demyelination

S Simpson, H Tan, P Otahal, B Taylor, A Ponsonby, R Lucas, L Blizzard, P Valery, J Lechner-Scott, C Shaw, D Williams, I van der Mei, K Dear, T Dwyer, S Broadley, T Kilpatrick, C Chapman, A Coulthard

(2016), Vol. 134, pp. 403-413, Acta Neurologica Scandinavica, Denmark, C1

Medical students' perceptions regarding the importance of nutritional knowledge and their confidence in providing competent nutrition practice

R Perlstein, S McCoombe, C Shaw, C Nowson

(2016), Vol. 140, pp. 27-34, Public Health, Netherlands, C1

Defining secondary progressive multiple sclerosis

J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, D Horakova, M Trojano, G Izquierdo, M Girard, P Duquette, A Prat, A Lugaresi, F Grand'maison, P Grammond, R Hupperts, R Alroughani, P Sola, C Boz, E Pucci, J Lechner-Scott, R Bergamaschi, C Oreja-Guevara, G Iuliano, V Van Pesch, F Granella, C Ramo-Tello, D Spitaleri, T Petersen, M Slee, F Verheul, R Ampapa, M Amato, P Mccombe, S Vucic, J Sánchez Menoyo, E Cristiano, M Barnett, S Hodgkinson, J Olascoaga, M Saladino, O Gray, C Shaw, F Moore, H Butzkueven, T Kalincik

(2016), Vol. 139, pp. 2395-2405, Brain, England, C1-1

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis

C Tao, S Simpson, I van der Mei, L Blizzard, E Havrdova, D Horakova, V Shaygannejad, A Lugaresi, G Izquierdo, M Trojano, P Duquette, M Girard, F Grand'Maison, P Grammond, R Alroughani, M Terzi, C Oreja-Guevara, S Sajedi, M Barnett, C Shaw

(2016), Vol. 87, pp. 1343-1349, Journal of neurology, neurosurgery & psychiatry, London, Eng., C1-1

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

M Warrender-Sparkes, T Spelman, G Izquierdo, M Trojano, A Lugaresi, F Grand'Maison, E Havrdova, D Horakova, C Boz, C Oreja-Guevara, R Alroughani, G Iuliano, P Duquette, M Girard, M Terzi, R Hupperts, P Grammond, T Petersen, R Fernandez-Bolaños, M Fiol, E Pucci, J Lechner-Scott, F Verheul, E Cristiano, V Van Pesch, T Petkovska-Boskova, F Moore, I Kister, R Bergamaschi, M Saladino, M Slee, M Barnett, M Amato, C Shaw, N Shuey, C Young, O Gray, L Kappos, H Butzkueven, T Kalincik, V Jokubaitis

(2016), Vol. 22, pp. 520-532, Multiple Sclerosis, England, C1-1

Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: A cohort study

G Pan, S Simpson, I van der Mei, J Charlesworth, R Lucas, A Ponsonby, Y Zhou, F Wu, B Taylor, K Dear, T Dwyer, L Blizzard, S Broadley, T Kilpatrick, D Williams, J Lechner-Scott, C Shaw, C Chapman, A Coulthard, P Valery

(2016), Vol. 87, pp. 1204-1211, Journal of Neurology, Neurosurgery and Psychiatry, London, Eng., C1-1

A new era in the treatment of multiple sclerosis

S Broadley, M Barnett, M Boggild, B Brew, H Butzkueven, R Heard, S Hodgkinson, A Kermode, J Lechner-Scott, R Macdonell, M Marriott, D Mason, J Parratt, S Reddel, C Shaw, M Slee, J Spies, B Taylor, W Carroll, T Kilpatrick, J King, P McCombe, J Pollard, E Willoughby

(2015), Vol. 203, pp. 139-141, Medical journal of Australia, Sydney, N.S.W., C1

Leptomeningeal rheumatoid nodules: diagnosis and failed therapeutics

C Nesbitt, L Willshire, D Quan, C Shaw, P Batchelor

(2015), Vol. 22, pp. 425-428, Journal of clinical neuroscience, Amsterdam, The Netherlands, C1-1

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

T Kalincik, V Jokubaitis, G Izquierdo, P Duquette, M Girard, P Grammond, A Lugaresi, C Oreja-Guevara, R Bergamaschi, R Hupperts, F Grand'Maison, E Pucci, V Van Pesch, C Boz, G Iuliano, R Fernandez-Bolanos, S Flechter, D Spitaleri, E Cristiano, F Verheul, J Lechner-Scott, M Amato, J Cabrera-Gomez, M Saladino, M Slee, F Moore, O Gray, M Paine, M Barnett, E Havrdova, D Horakova, T Spelman, M Trojano, H Butzkueven, C Shaw, MSBase Study Group

(2015), Vol. 21, pp. 1159-1171, Multiple sclerosis journal, London, Eng., C1-1

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

A He, T Spelman, V Jokubaitis, E Havrdova, D Horakova, M Trojano, A Lugaresi, G Izquierdo, P Grammond, P Duquette, M Girard, E Pucci, G Iuliano, R Alroughani, C Oreja-Guevara, R Fernandez-Bolaños, F Grand'Maison, P Sola, D Spitaleri, F Granella, M Terzi, J Lechner-Scott, V Van Pesch, R Hupperts, J Sánchez-Menoyo, S Hodgkinson, C Rozsa, F Verheul, H Butzkueven, T Kalincik, C Shaw, MSBase Study Group

(2015), Vol. 72, pp. 405-413, JAMA neurology, Chicago, Ill., C1-1

Predictors of disability worsening in clinically isolated syndrome

V Jokubaitis, T Spelman, T Kalincik, G Izquierdo, F Grand'Maison, P Duquette, M Girard, A Lugaresi, P Grammond, R Hupperts, J Cabrera-Gomez, C Oreja-Guevara, C Boz, G Giuliani, R Fernández-Bolaños, G Iuliano, J Lechner-Scott, F Verheul, V van Pesch, T Petkovska-Boskova, M Fiol, F Moore, E Cristiano, R Alroughani, R Bergamaschi, M Barnett, M Slee, N Vella, J Herbert, C Shaw, M Saladino, M Amato, D Liew, D Paolicelli, H Butzkueven, M Trojano, MSBasis Study Group

(2015), Vol. 2, pp. 479-491, Annals of clinical and translational neurology, Chichester, Eng., C1-1

Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry

J Rojas, L Patrucco, M Trojano, A Lugaresi, G Izquierdo, H Butzkueven, V Jokubaitis, P Duquette, M Girard, F Grand’Maison, P Grammond, C Oreja-Guevara, R Hupperts, C Boz, T Petersen, R Bergamaschi, G Giuliani, J Lechner-Scott, M Barnett, M Rio, V Van Pesch, M Amato, G Iuliano, M Fiol, M Slee, F Verheul, R Fernandez-Bolanos, D Poehlau, M Saladino, L Braber-Moerland, N Deri, W Oleschko-Arruda, J Cabrera-Gomez, M Paine, N Vella, I Kister, E Skromne, A Savino, C Shaw, F Moore, S Vucic, T Petkovska-Boskova, E Bacile, V Santiago, E Cristiano

(2015), Vol. 1, pp. 205521731560019-205521731560019, Multiple Sclerosis Journal - Experimental, Translational and Clinical, United States, C1

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy

S Broadley, M Barnett, M Boggild, B Brew, H Butzkueven, R Heard, S Hodgkinson, A Kermode, J Lechner-Scott, R Macdonell, M Marriott, D Mason, J Parratt, S Reddel, C Shaw, M Slee, J Spies, B Taylor, W Carroll, T Kilpatrick, J King, P McCombe, J Pollard, E Willoughby

(2014), Vol. 21, pp. 1847-1856, Journal of clinical neuroscience, London, England, C1-1

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations

S Broadley, M Barnett, M Boggild, B Brew, H Butzkueven, R Heard, S Hodgkinson, A Kermode, J Lechner-Scott, R Macdonell, M Marriott, D Mason, J Parratt, S Reddel, C Shaw, M Slee, J Spies, B Taylor, W Carroll, T Kilpatrick, J King, P McCombe, J Pollard, E Willoughby

(2014), Vol. 21, pp. 1857-1865, Journal of clinical neuroscience, London, England, C1

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies

S Broadley, M Barnett, M Boggild, B Brew, H Butzkueven, R Heard, S Hodgkinson, A Kermode, J Lechner-Scott, R Macdonell, M Marriott, D Mason, J Parratt, S Reddel, C Shaw, M Slee, J Spies, B Taylor, W Carroll, T Kilpatrick, J King, P McCombe, J Pollard, E Willoughby

(2014), Vol. 21, pp. 1835-1846, Journal of clinical neuroscience, London, England, C1

Risk of relapse phenotype recurrence in multiple sclerosis

T Kalincik, K Buzzard, V Jokubaitis, M Trojano, P Duquette, G Izquierdo, M Girard, A Lugaresi, P Grammond, F Grand'Maison, C Oreja-Guevara, C Boz, R Hupperts, T Petersen, G Giuliani, G Iuliano, J Lechner-Scott, M Barnett, D Liew, C Shaw

(2014), Vol. 20, pp. 1511-1522, Multiple sclerosis journal, London, Eng., C1-1

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent

T Spelman, O Gray, M Trojano, T Petersen, G Izquierdo, A Lugaresi, R Hupperts, R Bergamaschi, P Duquette, P Grammond, G Giuliani, C Boz, F Verheul, C Oreja-Guevara, M Barnett, F Grand'Maison, M Edite Rio, J Lechner-Scott, V Van Pesch, C Shaw

(2014), Vol. 76, pp. 880-890, Annals of neurology, London, Eng., C1-1

Fingolimod after natalizumab and the risk of short-term relapse

V Jokubaitis, V Li, T Kalincik, G Izquierdo, S Hodgkinson, R Alroughani, J Lechner-Scott, A Lugaresi, P Duquette, M Girard, M Barnett, F Grand'Maison, M Trojano, M Slee, G Giuliani, C Shaw, C Boz, D Spitaleri, F Verheul, D Liew

(2014), Vol. 82, pp. 1204-1211, Neurology, [Bethesda, Md.], C1-1

Predictors and dynamics of postpartum relapses in women with multiple sclerosis

S Hughes, T Spelman, O Gray, C Boz, M Trojano, A Lugaresi, G Izquierdo, P Duquette, M Girard, F Grand'Maison, P Grammond, C Oreja-Guevara, R Hupperts, R Bergamaschi, G Giuliani, J Lechner-Scott, M Barnett, M Edite Rio, V van Pesch, C Shaw

(2014), Vol. 20, pp. 739-746, Multiple sclerosis journal, London, Eng., C1-1

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

T Kalincik, T Spelman, M Trojano, P Duquette, G Izquierdo, P Grammond, A Lugaresi, R Hupperts, E Cristiano, V Van Pesch, F Grand'Maison, D La Spitaleri, M Rio, S Flechter, C Oreja-Guevara, G Giuliani, A Savino, M Amato, T Peterson, R Fernandez-Bolanos, R Bergamaschi, G Iuliano, C Boz, J Lechner-Scott, N Deri, O Gray, F Verheul, M Fiol, M Barnett, E van Munster, V Santiago, F Moore, M Slee, M Saladino, R Alroughani, C Shaw, K Kasa, T Petkovska-Boskova, L den Braber-Moerland, J Chapman, E Skromne, J Herbert, D Peohlau, M Needham, E Bacile, W Oleschko Arruda, M Paine, B Singhal, S Vucic, J Cabrera-Gomez, H Butkueven

(2013), Vol. 8, pp. 1-9, PLoS one, San Francisco, Calif., C1-1

The Australian multiple sclerosis (MS) immunotherapy study: A prospective, multicentre study of drug utilisation using the MSBase platform

V Jokubaitis, T Spelman, J Lechner-Scott, M Barnett, C Shaw, S Vucis, D Liew, H Butkueven, M Slee

(2013), Vol. 8, pp. 1-9, PLoS one, San Francisco, Calif., C1-1

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

T Kalincik, V Vivek, V Jokubaitis, J Lechner-Scott, M Trojano, G Izquierdo, A Lugaresi, F Grand-Maison, R Hupperts, C Oreja-Guevara, R Bergamaschi, G Iuliano, R Alroughani, P Van, M Amato, M Slee, F Verheul, R Fernandez-Bolanos, M Fiol, S La, E Cristiano, O Gray, J Cabrera-Gomez, V Shaygannejad, J Herbert, S Vucic, M Needham, T Petkovska-Boskova, C Sirbu, P Duquette, M Girard, P Grammond, C Boz, G Giuliani, M Rio, M Barnett, S Flechter, F Moore, B Singhal, E Bacile, M Saladino, C Shaw, E Skromne, D Poehlau, N Vella, T Spelman, D Liew, T Kilpatrick, H Butkueven

(2013), Vol. 136, pp. 3609-3617, Brain : a journal of neurology, Oxford, Eng., C1-1

Fluctuations of MS births and UV-light exposure

F Verheul, J Smolders, M Trojano, V Lepore, C Zwanikken, M Amato, F Grand'maison, H Butzkueven, M Marrosu, P Duquette, G Comi, G Izquierdo, P Grammond, G Lus, T Petersen, R Bergamaschi, G Giuliani, C Boz, M Barnett, C Shaw

(2013), Vol. 127, pp. 301-308, Acta neurologica scandinavica, London, Eng., C1-1

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

Claire Meyniel, Timothy Spelman, Vilija Jokubaitis, Maria Trojano, Guillermo Izquierdo, François Grand'Maison, Celia Oreja-Guevara, Cavit Boz, Alessandra Lugaresi, Marc Girard, Pierre Grammond, Gerardo Iuliano, Marcela Fiol, Jose Cabrera-Gomez, Ricardo Fernandez-Bolanos, Giorgio Giuliani, Jeannette Lechner-Scott, Edgardo Cristiano, Joseph Herbert, Tatjana Petkovska-Boskova, Roberto Bergamaschi, Vincent van Pesch, Fraser Moore, Norbert Vella, Mark Slee, Vetere Santiago, Michael Barnett, Eva Havrdova, Carolyn Young, Carmen-Adella Sirbu, Mary Tanner, Michelle Rutherford, Helmut Butzkueven, MSBasis Study Group, Cameron Shaw

(2012), Vol. 7, pp. 1-8, PLoS one, San Francisco, Calif., C1-1

Increasing age at disability milestones among MS patients in the MSBase Registry

I Kister, E Chamot, G Cutter, T Bacon, V Jokubaitis, S Hughes, O Gray, M Trojano, G Izquierdo, F Grand'Maison, P Duquette, A Lugaresi, P Grammond, C Boz, R Hupperts, T Petersen, G Giuliani, C Oreja-Guevara, G Iuliano, J Lechner-Scott, C Shaw, MSBase Investigators

(2012), Vol. 318, pp. 94-99, Journal of the neurological sciences, Amsterdam, The Netherlands, C1-1

The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase registry

S Hughes, T Spelman, M Trojano, A Lugaresi, G Izquierdo, F Grand'Maison, P Duquette, M Girard, P Grammond, C Oreja-Guevara, R Hupperts, C Boz, R Bergamaschi, G Giuliani, M Rio, J Lechner-Scott, V Van Pesch, G Iuliano, M Fiol, F Verheul, C Shaw, MSBase Study Group

(2012), Vol. 83, pp. 305-310, Journal of neurology, neurosurgery and psychiatry, London, Eng., C1-1

Frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude

J Lechner-Scott, B Spencer, T de Malmanche, J Attia, M Fitzgerald, M Trojano, F Grand'Maison, J Gomez, G Izquierdo, P Duquette, M Girard, P Grammond, C Oreja-Guevara, R Hupperts, P Bergamaschi, C Boz, G Giuliani, V van Pesch, G Iuliano, M Fiol, E Cristiano, F Verheul, M Laura Saladino, M Slee, M Barnett, N Deri, S Flechter, N Vella, C Shaw, J Herbert, F Moore, T Petkovska-Boskova, V Jokubaitis, H Butzkueven

(2011), Vol. 18, pp. 974-982, Multiple sclerosis, London, Eng., C1-1

A proliferative adult human oligodendrocyte progenitor

N Scolding, P Rayner, J Sussman, C Shaw, D Compston, D Compston

(1995), Vol. 6, pp. 441-445, NeuroReport, Philadelphia, Pa., C1-1